Literature DB >> 4146024

Immune complex disease.

P M Carter.   

Abstract

Mesh：

Substances：

Year:  1973        PMID： 4146024      PMCID： PMC1006090          DOI： 10.1136/ard.32.3.265

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  13 in total

1.  STREPTOCOCCAL RELATED GLOMERULONEPHRITIS. I. ISOLATION, IMMUNOCHEMISTRY AND COMPARATIVE CHEMISTRY OF SOLUBLE FRACTIONS FROM TYPE 12 NEPHRITOGENIC STREPTOCOCCI AND HUMAN GLOMERULI.

Authors:  A S MARKOWITZ; C F LANGE
Journal:  J Immunol       Date:  1964-04       Impact factor: 5.422

Review 2.  Immune-complex disease.

Authors:  C L Christian
Journal:  N Engl J Med       Date:  1969-04-17       Impact factor: 91.245

Review 3.  Complement in human disease.

Authors:  P H Schur; K F Austen
Journal:  Annu Rev Med       Date:  1968       Impact factor: 13.739

4.  Immunologic factors and clinical activity in systemic lupus erythematosus.

Authors:  P H Schur; J Sandson
Journal:  N Engl J Med       Date:  1968-03-07       Impact factor: 91.245

5.  Arthritis of hepatitis associated with Australia antigen.

Authors:  D K Onion; C S Crumpacker; B C Gilliland
Journal:  Ann Intern Med       Date:  1971-07       Impact factor: 25.391

6.  Serial complement component alterations in acute glomerulonephritis and systemic lupus erythematosus.

Authors:  P F Kohler; R Ten Bensel
Journal:  Clin Exp Immunol       Date:  1969-02       Impact factor: 4.330

7.  Systemic lupus erythematosus and myxovirus.

Authors:  F Györkey; K W Min; J G Sincovics; P Györkey
Journal:  N Engl J Med       Date:  1969-02-06       Impact factor: 91.245

8.  Immune complex disease. II. The role of circulatory dynamics and glomerular filtration in the development of experimental glomerulonephritis.

Authors:  F G Germuth; W A Kelemen; A D Pollack
Journal:  Johns Hopkins Med J       Date:  1967-04

9.  Experimental studies on the immunologic and histologic effects of prolonged exposure to antigen. I. Distribution of allergic lesions following multiple injections of bovine albumin, bovine gamma globulin, and albumin and globulin together with special reference to the occurrence of granulomatous arteritis.

Authors:  R H HEPTINSTALL; F G GERMUTH
Journal:  Bull Johns Hopkins Hosp       Date:  1957-02

10.  THE ROLE OF SERUM COMPLEMENT IN CHEMOTAXIS OF LEUKOCYTES IN VITRO.

Authors:  P A WARD; C G COCHRANE; H J MUELLER-EBERHARD
Journal:  J Exp Med       Date:  1965-08-01       Impact factor: 14.307
View more
  9 in total

1.  Self-perpetuating mechanisms of immunoglobulin G aggregation in rheumatoid inflammation.

Authors:  J Lunec; D R Blake; S J McCleary; S Brailsford; P A Bacon
Journal:  J Clin Invest       Date:  1985-12       Impact factor: 14.808

2.  Altered glycan accessibility on native immunoglobulin G complexes in early rheumatoid arthritis and its changes during therapy.

Authors:  J Stümer; M H C Biermann; J Knopf; I Magorivska; A Kastbom; A Svärd; C Janko; R Bilyy; G Schett; C Sjöwall; M Herrmann; L E Muñoz
Journal:  Clin Exp Immunol       Date:  2017-06-13       Impact factor: 4.330

3.  Acute renal failure following intravenous streptokinase infusion for acute myocardial infarction.

Authors:  Y Birnbaum; B Strasberg; E Rechavia; Y Neuman; B Stahl
Journal:  West J Med       Date:  1993-04

Review 4.  IgM paraproteins.

Authors:  J R Hobbs; P M Carter; K B Cooke; M Foster; C J Oon
Journal:  J Clin Pathol Suppl (Assoc Clin Pathol)       Date:  1975

5.  The Arthus reaction in guinea-pig knee joints. A test for anti-inflammatory drugs.

Authors:  A Blackham; H Radziwonik; I H Shaw
Journal:  Agents Actions       Date:  1975-12

6.  Gold-induced immune complex nephritis in seronegative rheumatoid arthritis.

Authors:  B V Skrifvars; T S Törnroth; G N Tallqvist
Journal:  Ann Rheum Dis       Date:  1977-12       Impact factor: 19.103

7.  Immune complex disease in a chronic monkey study with a humanised, therapeutic antibody against CCL20 is associated with complement-containing drug aggregates.

Authors:  Susan B Laffan; Andrew S Thomson; Shing Mai; Cindy Fishman; Takahito Kambara; Kiran Nistala; James T Raymond; Shugui Chen; Thulasi Ramani; Laura Pageon; Rodd Polsky; Mark Watkins; Gemma Ottolangui; John R White; Curtis Maier; Michael Herdman; Gerben Bouma
Journal:  PLoS One       Date:  2020-04-23       Impact factor: 3.240

Review 8.  COVID-19-A Theory of Autoimmunity Against ACE-2 Explained.

Authors:  Philip McMillan; Thomas Dexhiemer; Richard R Neubig; Bruce D Uhal
Journal:  Front Immunol       Date:  2021-03-23       Impact factor: 7.561

Review 9.  Immune response to SARS-CoV-2 variants: A focus on severity, susceptibility, and preexisting immunity.

Authors:  Eman Alefishat; Herbert F Jelinek; Mira Mousa; Guan K Tay; Habiba S Alsafar
Journal:  J Infect Public Health       Date:  2022-01-13       Impact factor: 3.718
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.